Grandfield & Dodd, LLC Incyte Corp Transaction History
Grandfield & Dodd, LLC
- $1.53 Billion
- Q1 2025
A detailed history of Grandfield & Dodd, LLC transactions in Incyte Corp stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 21,065 shares of INCY stock, worth $1.31 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
21,065
Previous 20,207
4.25%
Holding current value
$1.31 Million
Previous $1.4 Million
8.6%
% of portfolio
0.08%
Previous 0.09%
Shares
31 transactions
Others Institutions Holding INCY
# of Institutions
703Shares Held
190MCall Options Held
909KPut Options Held
489K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.91 Billion23.54% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.33 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.22 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$927 Million0.64% of portfolio
-
State Street Corp Boston, MA10MShares$623 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $13.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...